Skip to content
Altius – Lifestyle
Author:
Scribe Therapeutics Inc.
Scribe Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
September 2, 2026
Scribe Therapeutics to Participate in Upcoming Investor Conferences
September 1, 2026
Scribe Therapeutics Announces Closing of Initial Public Offering, Full Exercise of Underwriters’ Option to Purchase Additional Shares, and Closing of the Concurrent Private Placement
July 27, 2026
Scribe Therapeutics Announces Pricing of Upsized Initial Public Offering
July 23, 2026